| Financial Year |
March 31 2023 |
| Monetary Funds |
530,662,412.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
51,426,830.88 |
| Accounts Receivable |
584,722,963.84 |
| Advances to Suppliers |
60,134,016.46 |
| Other Receivables |
25,973,597.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
823,772,943.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,194,207.00 |
| Other Current Assets |
115,617,308.14 |
| Total Current Assets |
2,215,831,603.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
22,839,124.77 |
| Long-term Equity Investment |
-- |
| Investment Properties |
43,034,640.08 |
| Fixed Assetes |
1,036,421,248.27 |
| Under-construction Projects |
98,689,445.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
301,966,861.05 |
| R&D expenses |
29,656,547.63 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
65,271,502.84 |
| Deferred Income Tax Assets |
115,960,672.84 |
| Other Non-Current Assets |
67,734,066.69 |
| Sub-Total of Non-Current Assets |
1,996,921,179.58 |
| Total Assets |
4,212,752,783.11 |
| Short-Term Loans |
289,444,568.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
148,688,855.00 |
| Accounts Payable |
737,298,693.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
117,493,549.55 |
| Taxes Payable |
21,007,772.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,445,885.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
184,429,497.35 |
| Other Current Liabilities |
1,025,155.30 |
| Sub-Total of Current Liabilities |
1,662,100,029.42 |
| Long-term Loans |
427,294,672.25 |
| Bonds Payable |
256,008,009.98 |
| Long-Term Accounts Payable |
52,418,141.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,835,445.14 |
| Deferred Income Tax Liabilities |
74,572,578.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,059,899,427.65 |
| Total Liabilities |
2,721,999,457.07 |
| Paid-In Capital(Or Share Stock) |
150,447,992.00 |
| Capital Surplus |
2,063,827,506.26 |
| Surplus Reserve |
94,759,848.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-835,535,627.74 |
| Minority Stockholder's Interest |
13,889,869.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,476,863,456.93 |
| Owner's Equity（Stockholder's Equity） |
1,490,753,326.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,212,752,783.11 |
